Bay Colony Advisory Group, Inc D Halozyme Therapeutics, Inc. Transaction History

Bay Colony Advisory Group, Inc D

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	BUY	$37.35 - $48.3 $166,207 - $214,935	4,450 New	4,450 $218,000
Q1 2021 May 13, 2021	SELL	$39.51 - $51.45 $213,354 - $277,830	-5,400 Closed	0 $0
Q4 2020 Feb 02, 2021	SELL	$25.81 - $43.62 $61,944 - $104,688	-2,400 Reduced 30.77%	5,400 $231,000
Q3 2020 Nov 25, 2020	BUY	$25.74 - $29.63 $200,772 - $231,114	7,800 New	7,800 $205,000

543

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.62B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Bay Colony Advisory Group, Inc D, based on Form 13F filings with the SEC.

Stay updated on Bay Colony Advisory Group, Inc D with notifications on news.